Production (Stage)
Carisma Therapeutics, Inc.
CARM
$0.4297
-$0.0219-4.85%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.27M | -17.64M | -12.70M | -11.16M | -18.98M |
| Total Depreciation and Amortization | 661.00K | 669.00K | 737.00K | 255.00K | 1.69M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.50M | 607.00K | 2.08M | 3.75M | 2.72M |
| Change in Net Operating Assets | -2.96M | 8.01M | -3.13M | -8.97M | -7.86M |
| Cash from Operations | -10.07M | -8.35M | -13.02M | -16.12M | -22.43M |
| Capital Expenditure | -- | 0.00 | 0.00 | -106.00K | -17.00K |
| Sale of Property, Plant, and Equipment | 524.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 524.00K | 0.00 | 0.00 | -106.00K | -17.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 686.00K |
| Total Debt Repaid | -631.00K | -597.00K | -590.00K | 71.00K | -1.62M |
| Issuance of Common Stock | 5.00K | -- | 129.00K | 2.00K | 2.29M |
| Repurchase of Common Stock | -- | -23.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -626.00K | -620.00K | -461.00K | 73.00K | 1.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.17M | -8.97M | -13.48M | -16.15M | -21.09M |